Production and characterization of monoclonal antibodies against the lethal factor component of Bacillus anthracis lethal toxin.

Infection and Immunity
S F LittleA M Friedlander

Abstract

The lethal toxin of Bacillus anthracis consists of two components, protective antigen and lethal factor. Protective antigen is cleaved after binding to cell receptors, yielding a receptor-bound fragment that binds lethal factor. Sixty-one monoclonal antibodies to the lethal factor protein have been characterized for specificity, antibody subtype, and ability to neutralize lethal toxin. Three monoclonal antibodies (10G3, 2E7, and 3F6) neutralized lethal toxin in Fisher 344 rats. However, in a macrophage cytolysis assay, monoclonal antibodies 10G3, 2E7, 10G4, 10D4, 13D10, and 1D8, but not 3F6, were found to neutralize lethal toxin. Binding studies showed that five of the monoclonal antibodies that neutralized lethal toxin in the macrophage assay (10G3, 2E7, 10G4, 10D4, and 13D10) did so by inhibiting the binding of lethal factor to the protective antigen fragment bound to cells. Monoclonal antibody 1D8, which was also able to neutralize lethal toxin activity after lethal factor was prebound to cell-bound protective antigen, only partially inhibited binding of lethal factor to protective antigen. Monoclonal antibody 3F6 did not inhibit the binding of lethal factor to protective antigen. A competitive-binding enzyme-linked immunoso...Continue Reading

References

Jan 1, 1986·Toxicon : Official Journal of the International Society on Toxinology·E J MachugaJ W Burnett
Jan 1, 1988·Toxicon : Official Journal of the International Society on Toxinology·D K LarsonJ W Burnett
Jan 1, 1988·Methods in Enzymology·S H Leppla
Jan 1, 1986·Methods in Enzymology·V van Heyningen
May 15, 1985·Analytical Biochemistry·M G Redinbaugh, W H Campbell
Sep 1, 1972·Immunochemistry·A M PappenheimerA A Harper
Aug 26, 1983·Journal of Immunological Methods·V Van HeyningenS Van Heyningen
May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·S H Leppla

❮ Previous
Next ❯

Citations

Apr 30, 2015·Expert Opinion on Investigational Drugs·Lernik OhanjanianPeter Q Eichacker
Jul 31, 2007·Future Microbiology·Karla D Passalacqua, Nicholas H Bergman
Jun 3, 2011·PloS One·Julie PrigentStéphanie Simon
Sep 24, 2008·BMC Infectious Diseases·Rasha HammamiehJohn Ezzell
Nov 10, 2011·Toxins·Zhaochun ChenRobert Purcell
Dec 17, 2011·Toxins·Jeffrey W FroudeThibaut Pelat
Jul 24, 2012·Toxins·Siu-Kei Chow, Arturo Casadevall
Feb 12, 2009·Future Microbiology·Anette Schneemann, Marianne Manchester
Jul 19, 2013·Clinical & Developmental Immunology·Guipeng DingBrian Cao
Aug 5, 2009·Proceedings of the National Academy of Sciences of the United States of America·Zhaochun ChenRobert H Purcell
Jun 9, 2005·Clinical and Diagnostic Laboratory Immunology·Phillip R PittmanKelly T McKee
Oct 14, 2003·Nature Biotechnology·Martha A WildKatherine S Bowdish
Oct 23, 2003·Annual Review of Cell and Developmental Biology·R John Collier, John A T Young
Aug 18, 2010·Antimicrobial Agents and Chemotherapy·Gaobing WuZiduo Liu
Jan 15, 2011·FEMS Immunology and Medical Microbiology·Stephen F LittleDiana E Fisher
Sep 9, 2004·Microbiology and Molecular Biology Reviews : MMBR·Holger BarthBradley G Stiles
Sep 15, 2004·FEMS Immunology and Medical Microbiology·Les BaillieDiane Williamson
Oct 13, 2006·Infection and Immunity·John A MiksztaRobert G Ulrich
Dec 14, 1999·Microbes and Infection·S F Little, B E Ivins
Sep 15, 2005·Vaccine·Mingtao ZengMichael E Pichichero

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.